Ignite Creation Date:
2024-05-06 @ 3:42 PM
Last Modification Date:
2024-10-26 @ 1:54 PM
Study NCT ID:
NCT04722848
Status:
RECRUITING
Last Update Posted:
2024-02-07
First Post:
2021-01-20
Brief Title:
Sequential Treatment With Ponatinib and Blinatumomab vs Chemotherapy and Imatinib in Newly Diagnosed Adult Ph ALL
Sponsor:
Gruppo Italiano Malattie EMatologiche dellAdulto
Organization:
Gruppo Italiano Malattie EMatologiche dellAdulto
Organization Data
Organization:
Gruppo Italiano Malattie EMatologiche dellAdulto
Class:
OTHER
Study ID:
ALL2820
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Gruppo Italiano Malattie EMatologiche dellAdulto
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None